Reply to Verweij et al.
Publication
, Journal Article
Uyeki, TM; Ison, MG; Wolfe, CR; Pavia, AT
Published in: Clin Infect Dis
January 2, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
January 2, 2020
Volume
70
Issue
2
Start / End Page
350 / 351
Location
United States
Related Subject Headings
- Societies
- Seasons
- Microbiology
- Humans
- Disease Outbreaks
- Communicable Diseases
- Chemoprevention
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Uyeki, T. M., Ison, M. G., Wolfe, C. R., & Pavia, A. T. (2020). Reply to Verweij et al. Clin Infect Dis, 70(2), 350–351. https://doi.org/10.1093/cid/ciz568
Uyeki, Timothy M., Michael G. Ison, Cameron R. Wolfe, and Andrew T. Pavia. “Reply to Verweij et al.” Clin Infect Dis 70, no. 2 (January 2, 2020): 350–51. https://doi.org/10.1093/cid/ciz568.
Uyeki TM, Ison MG, Wolfe CR, Pavia AT. Reply to Verweij et al. Clin Infect Dis. 2020 Jan 2;70(2):350–1.
Uyeki, Timothy M., et al. “Reply to Verweij et al.” Clin Infect Dis, vol. 70, no. 2, Jan. 2020, pp. 350–51. Pubmed, doi:10.1093/cid/ciz568.
Uyeki TM, Ison MG, Wolfe CR, Pavia AT. Reply to Verweij et al. Clin Infect Dis. 2020 Jan 2;70(2):350–351.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
January 2, 2020
Volume
70
Issue
2
Start / End Page
350 / 351
Location
United States
Related Subject Headings
- Societies
- Seasons
- Microbiology
- Humans
- Disease Outbreaks
- Communicable Diseases
- Chemoprevention
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences